tiprankstipranks
Trending News
More News >
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market

VYNE Therapeutics (VYNE) Revenue

Compare
1,836 Followers

VYNE Therapeutics Revenue

VYNE Therapeutics had a revenue of 202.00K in the quarter ending Mar 31, 2025, with 140.48%. This bring the company's revenue in the last twelve months to 605.00K, Decreased 20.76%. In the fiscal year ending Dec 31, 2024, VYNE Therapeutics had annual revenue of 501.00K with 18.16% growth.
Revenue (ttm)
605.00K
Revenue Growth
43.03%
P/S Ratio
30.30
Revenue/Employee
$38,538
Employees
13
Market Cap
$15.18M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
501.00K77.00K+18.16%
Dec 31, 2023
424.00K-53.00K-11.11%
Dec 31, 2022
477.00K-14.28M-96.77%
Dec 31, 2021
14.76M-6.24M-29.71%
Dec 31, 2020
20.99M20.55M+4,638.83%
Dec 31, 2019
443.00K-10.20M-95.84%
Dec 31, 2018
10.64M6.06M+132.21%
Dec 31, 2017
4.58M3.91M+579.82%
Dec 31, 2016
674.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis